Place an order request to the broker. The personal manager will contact you to confirm the order.

Order Summary

Asset: Select instrument
Quantity: -
Price per Unit: ? This price is indicative and shown for informational purposes only. The final execution price may change. -
Total Amount: -

Order Expiration

Order remains active until you cancel it or it gets filled

Order expires at the end of the selected day

Order Placed Successfully

Your order has been submitted! Our team will contact you shortly to confirm.

Order Type: -
Asset: -
Quantity: -
Total Amount: -
Manually record a past trade to keep your portfolio up to date. This helps track your P&L accurately.
Total Amount: $0.00

Trade Added Successfully

Trade recorded! Your portfolio data will be recalculated.

Type: -
Asset: -
Quantity: -
Price: -
Total: -

Chat Options

Web Search
Search the internet for recent information
Portfolio Context
Include your portfolio in the conversation
Market Data
Access real-time market information
Watchlist Context
Include your watchlist companies

Investment Managers Series Trus (IREX)

2026-08-21T14:20:50.182213+00:00

Key Updates

IREX declined -14.08% since the last report, falling from $18.04 to the current $15.50. This reverses the sharp +14.17% rally documented in the prior report and returns the price to levels comparable to those seen in mid-August prior to that spike. No company-specific news was identified for IREX during this period; the move is price-driven, continuing the pattern of extreme whipsaw volatility observed across the last four consecutive reports (13.85 → 15.30 → 15.80 → 18.04 → 15.50).

Current Trend

IREX remains in a deeply bearish trend on a YTD basis (-48.95%) and over six months (-42.46%). Despite the brief rebound to $18.04, the 5-day (-9.14%) and 1-month (-10.40%) figures confirm renewed downside pressure. Near-term support is observed around $13.85 (the August 19 low), while resistance sits near $18.04 (the recent high reached before the current reversal). The current price of $15.50 sits within this range, reflecting a lack of directional stability rather than a clear trend reversal.

Investment Thesis

No fundamental company-specific catalysts have been identified for IREX across the recent reporting periods. Contextual news flow is dominated by third-party issuers (BMO/REX Shares, Tradr) expanding leveraged and inverse single-stock/sector ETF and ETN offerings, alongside a Bloomberg feature on the growing (and risky) practice of holding leveraged ETFs long-term. Given IREX's extreme realized volatility—48.95% YTD decline punctuated by repeated double-digit swings in both directions between reports—its price behavior is consistent with a high-beta or leveraged/derivative-linked structure subject to compounding decay rather than a traditional buy-and-hold equity thesis.

Thesis Status

The thesis remains bearish and has not improved. The brief rally to $18.04 proved unsustainable, with the position giving back the entire gain in the subsequent period. This pattern reinforces the risk highlighted in the Bloomberg article regarding daily-reset leveraged products losing value over time even amid volatile, range-bound underlying moves. The absence of any company-specific positive catalyst, combined with continued severe drawdowns, confirms a deteriorating and high-risk profile.

Key Drivers

No direct news on IREX was published in the covered period. Relevant market context includes: continued expansion of leveraged/inverse ETN and ETF products by BMO and REX Shares, including new 3x Brazil/Japan/Taiwan ETNs (PR Newswire) and 3x corporate bond ETNs (PR Newswire); Tradr's continued rollout of single-stock leveraged ETFs on Meta, AXT, Coherent, and Lightwave Logic (PR Newswire) and on Everspin, SiTime, and UMC (PR Newswire); and a Bloomberg report on retail and institutional investors increasingly holding leveraged ETFs beyond their intended short-term trading horizon, raising decay-related concerns (Bloomberg).

Technical Analysis

IREX trades at $15.50, down -1.90% intraday and -9.14% over five days, indicating accelerating short-term selling pressure following the failed breakout above $18.00. Resistance is now established near $18.04 (recent high), with support near $13.85 (prior swing low). The stock remains within this $13.85–$18.04 trading band, with no confirmed breakout in either direction. The rapid sequence of double-digit percentage swings between reports reflects elevated realized volatility and an absence of a stable trend, characteristic of high-beta or leverage-linked instruments.

Bull Case

  • Continued expansion of the leveraged/thematic ETF industry by major issuers signals sustained investor interest and liquidity in high-volatility products, which may support trading activity in comparable vehicles: PR Newswire, PR Newswire
  • Rising institutional and retail engagement with leveraged products, as noted by Bloomberg, indicates continued market attention that could sustain liquidity and trading interest: Bloomberg
  • Structural growth of the broader ETF industry, evidenced by Guinness Atkinson's new share class launch, reflects continued capital inflows into fund vehicles generally: PR Newswire
  • New leveraged corporate bond ETN launches (HYGU/HYGD/LQDU/LQDD) indicate an active risk-on trading environment for leveraged products that could extend to related categories: PR Newswire
  • Historical price pattern shows IREX capable of sharp double-digit rebounds (+14.17%, +10.44%, +3.29% in preceding reports), suggesting potential for a near-term technical bounce from current support levels.

Bear Case

  • Severe, sustained value destruction with a -48.95% YTD and -42.46% six-month decline points to structural erosion consistent with leveraged-product decay rather than temporary weakness.
  • Bloomberg explicitly warns that holding leveraged ETFs beyond short-term trading horizons causes performance divergence from intended exposure due to daily rebalancing—a direct risk factor for continued IREX exposure: Bloomberg
  • The reversal of the entire prior +14.17% gain within one reporting period underscores the instrument's lack of trend stability and elevated capital-at-risk profile.
  • No positive company-specific catalysts have appeared in recent news flow; all related news concerns unrelated leveraged products from other issuers, offering no fundamental support for IREX: PR Newswire, PR Newswire
  • Explicit risk disclosures accompanying comparable leveraged product launches caution that such instruments are unsuitable for buy-and-hold strategies and carry potential for total capital loss, a risk framework directly applicable to IREX's volatility profile: PR Newswire

CapPilot is AI-powered and can make mistakes. Please double-check responses.

CapPilot leverages generative AI to distill market insights and analysis, as well as answer your questions in chat. While we work hard to ensure accuracy, AI-generated content may occasionally contain inaccuracies or outdated information.

We value your feedback — reporting errors helps us continuously improve.